| Rectal Carcinoma altered in cohorts of …ALTERED_INderived163 of 163show fewer |
|---|
| ← altered in cohorts of | TAF4 152 / 171 cases (89 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOP1 152 / 171 cases (89 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CD40 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHD6 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNMT3B 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPB41L1 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNB1 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RALGAPB 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAU1 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF831 151 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARFGEF2 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDH4 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP250 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DDX27 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DLGAP4 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM217B 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNAS 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HNF4A 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | JPH2 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIAA1755 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMA5 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MATN4 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMP9 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA3 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCK1 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R16B 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PREX1 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBPJL 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIMS4 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SGK2 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC12A5 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOGA1 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRPC4AP 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF334 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNFX1 150 / 171 cases (88 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BLCAP 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BMP7 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPI 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BPIFB3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COX4I2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTCFL 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EDN3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EMILIN3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EYA2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM83D 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FOXS1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GCNT7 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HM13 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LPIN3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH8 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYL9 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYT1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCOA5 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHACTR3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGT 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLCG1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTPN1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBL1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBM39 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPN2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC13A3 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35C2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC9A8 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPO11 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SUN5 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYCP2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TSHZ2 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBP1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMYND8 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF512B 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSWIM1 149 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADIG 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C20orf173 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNBD2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPPIN-WFDC6 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERGIC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM209B 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM210B 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GDAP1L1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAFB 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MMP24 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYH7B 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSBPL2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSER1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCIF1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLTP 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAE1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RTF2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMG2 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SERINC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNAI1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53RK 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTI1 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VAPB 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC11 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC13 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WFDC3 148 / 171 cases (87 %) · ssm · TCGA-READ | — | — | Rectal Adenocarcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APC 5,400 / 7,237 cases (75 %) · ssm · crc_msk_2026 · largest of 3 cohorts | — | — | Rectal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 5,295 / 7,237 cases (73 %) · ssm · crc_msk_2026 · largest of 3 cohorts | — | — | Rectal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KRAS 3,096 / 7,237 cases (43 %) · ssm · crc_msk_2026 · largest of 2 cohorts | — | — | Rectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 61 / 155 cases (39 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 35 / 155 cases (23 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CA 1,486 / 7,237 cases (21 %) · ssm · crc_msk_2026 · largest of 2 cohorts | — | — | Rectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 28 / 155 cases (18 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 25 / 155 cases (16 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 25 / 155 cases (16 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBXW7 1,127 / 7,237 cases (16 %) · ssm · crc_msk_2026 · largest of 2 cohorts | — | — | Rectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 24 / 155 cases (15 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TCF7L2 1,088 / 7,035 cases (15 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMAD4 1,078 / 7,237 cases (15 %) · ssm · crc_msk_2026 · largest of 3 cohorts | — | — | Rectal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 23 / 155 cases (15 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 912 / 7,237 cases (13 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SOX9 869 / 7,237 cases (12 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRAF 813 / 7,237 cases (11 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 805 / 7,237 cases (11 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2B 653 / 6,120 cases (11 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RNF43 734 / 7,237 cases (10 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRS 708 / 7,237 cases (9.8 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX3 658 / 7,035 cases (9.4 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATM 646 / 7,237 cases (8.9 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRT 636 / 7,237 cases (8.8 %) · ssm · crc_msk_2026 · largest of 2 cohorts | — | — | Rectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 605 / 7,237 cases (8.4 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH3 571 / 7,237 cases (7.9 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AMER1 550 / 7,237 cases (7.6 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT1 550 / 7,237 cases (7.6 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MSH3 453 / 6,120 cases (7.4 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CREBBP 517 / 7,237 cases (7.1 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CTNNB1 503 / 7,237 cases (7.0 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANKRD11 468 / 7,035 cases (6.7 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PREX2 404 / 6,120 cases (6.6 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2A 470 / 7,237 cases (6.5 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CARD11 469 / 7,237 cases (6.5 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH1 459 / 7,237 cases (6.3 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRCA2 454 / 7,237 cases (6.3 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPEN 451 / 7,237 cases (6.2 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTEN 446 / 7,237 cases (6.2 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA5 443 / 7,237 cases (6.1 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MGA 430 / 7,035 cases (6.1 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1B 441 / 7,237 cases (6.1 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POLE 441 / 7,237 cases (6.1 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2A 437 / 7,237 cases (6.0 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLT4 432 / 7,237 cases (6.0 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB4 429 / 7,237 cases (5.9 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMARCA4 425 / 7,237 cases (5.9 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AXIN2 423 / 7,237 cases (5.8 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TGFBR2 416 / 7,237 cases (5.7 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNRF3 160 / 2,789 cases (5.7 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASXL1 410 / 7,237 cases (5.7 %) · ssm · crc_msk_2026 · largest of 2 cohorts | — | — | Rectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NF1 405 / 7,237 cases (5.6 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3R1 395 / 7,237 cases (5.5 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MTOR 394 / 7,237 cases (5.4 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EP300 389 / 7,237 cases (5.4 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB3 389 / 7,237 cases (5.4 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALK 388 / 7,237 cases (5.4 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTCH1 385 / 7,237 cases (5.3 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB2 378 / 7,237 cases (5.2 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POLD1 366 / 7,035 cases (5.2 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CIC 373 / 7,237 cases (5.2 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NCOR1 373 / 7,237 cases (5.2 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | INPPL1 315 / 6,120 cases (5.1 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SETD2 370 / 7,237 cases (5.1 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AR 365 / 7,237 cases (5.0 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TERT 362 / 7,237 cases (5.0 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |